Dernières nouvelles pour Aptose Biosciences (OTC:APTOF) Stock

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

APTOSE BIOSCIENCES INC by Aptose Biosciences. Inc.

Comments

Aptose Biosciences

Actualités

Dernières nouvelles pour Aptose Biosciences (OTC:APTOF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL